Fig. 3From: Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphomaKaplan–Meier estimates. Overall Survival in two Lymphoma cohorts treated with Tel-eVax™/Chemotherapy: vaccinated USA (this study) and vaccinated Italy [28]. Median survival weeks are shownBack to article page